Tag: genetics

THCA Vapes Dominate Premium Cannabis Market as Area 52 Named Best THCA Vape of 2025

BROWNS SUMMIT, N.C., July 04, 2025 (GLOBE NEWSWIRE) --  Black Tie CBD, a nationally recognized leader in premium hemp-derived cannabis products, is proud to announce the launch of its 2025 THCA Flower Strain Drop—a curated collection of lab-tested, indoor-grown, dispensary-grade and federally legal THCA flower strains designed to meet rising consumer demand for compliant, high-potency cannabis alternatives.

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions

Las Vegas, NV, July 03, 2025 (GLOBE NEWSWIRE) -- Area 52, a vanguard in cannabinoid science and botanical engineering, today announced the debut of its 2025 THCA Snow Caps collection, a groundbreaking line of premium hemp flower completely enveloped in pure THCA diamonds. Engineered to “Alienize Your Mind,” these crystalline-coated buds represent a new frontier in potency and sensory experience for the discerning cannabis connoisseur.

VANCOUVER, British Columbia, July 02, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon”, or the “Company”), Canada’s leading premium licensed producer focused on cultivating and selling organic certified, premium and super-premium cannabis products, is proud to announce the launch of its new 1964 Supply Co.™ (“1964”) All-in-One (“AIO”) Full Spectrum Extract (“FSE”) Resin Vapes into the Canadian market.

Lynozyfic is a bispecific antibody directing T cells to kill multiple myeloma cancer cells; multiple myeloma is the second most common blood cancer 

SAN DIEGO, July 02, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers of Tempus AI, Inc. (NASDAQ: TEM) common stock between August 6, 2024 and May 27, 2025, all dates inclusive (the “Class Period”), have until August 12, 2025 to seek appointment as lead plaintiff of the Tempus AI class action lawsuit. Captioned Shouse v. Tempus AI, Inc., No. 25-cv-06534 (N.D. Ill.), the Tempus AI class action lawsuit charges Tempus AI as well as certain of Tempus AI’s top executives with violations of the Securities Exchange Act of 1934.